A “Game of Thrones” in Metastatic Renal Cell Carcinoma: Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors and Mammalian Target of Rapamycin Inhibitors Battling for Position

অনুরূপ উপাদানগুলি

• Mammalian target of rapamycin, Akt, and phosphatidylinositol 3-kinase signaling
  অনুযায়ী: Pal, Sumanta K., অন্যান্য
  প্রকাশিত: (2010)
• Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma
  অনুযায়ী: Pal, Sumanta Kumar, অন্যান্য
  প্রকাশিত: (2011)
• Game of Thrones
  অনুযায়ী: Revolon, Sandra
  প্রকাশিত: (2020)
• Vascular endothelial growth factor receptor tyrosine kinase inhibitors in metastatic renal cell cancer: latest results and clinical implications
  অনুযায়ী: Aslam, Shahzeena, অন্যান্য
  প্রকাশিত: (2013)
• Outcomes of Unselected Patients with Metastatic Clear-Cell Renal Cell Carcinoma Treated with Front-Line Pazopanib Therapy Followed by Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors (VEGFR-TKI) or Mammalian Target of Rapamycin Inhibitors (mTORi): A Single Institution Experience
  অনুযায়ী: Matrana, Marc R., অন্যান্য
  প্রকাশিত: (2015)